Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2728 results

Sort By:

Quality of Life in Breast Cancer Survivors Who Were Pregnant During Their Cancer Treatment

Study ID: NCT07191496
Start Date: 2026-02-22
End Date: 2026-06-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Questionnaire

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Neuroinflammation in Asymptomatic Carotid Artery Disease - Imaging Substudy

Study ID: NCT05238961
Start Date: 2026-04-01
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

20

Intervention / Treatment

[18F]DPA-714

Sponsor

University of Alabama at Birmingham

Source: clinicaltrials.gov

Share:
Add to list

Exercise Effects in Native American Adolscents

Study ID: NCT06758310
Start Date: 2025-11-16
End Date: 2025-12-20
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

10

Intervention / Treatment

Individualized Exercise

Sponsor

Midwestern University

Source: clinicaltrials.gov

Share:
Add to list

Modulation of the Bone Immune Microenvironment Following Cabozantinib Treatment of Bone Metastatic Clear Cell Renal Cell Carcinoma: Proof of Concept Study

Study ID: NCT07187869
Start Date: 2026-03-31
End Date: 2029-04-07
Study Type

Interventional

Study Phase

Phase1

No. of Participants

16

Intervention / Treatment

Cabozantinib

Nivolumab

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

A Study to Investigate Efficacy and Safety of a TCA108 in Participants ≥18 Years With Uncontrolled Hypertension

Study ID: NCT07030101
Start Date: 2026-03
End Date: 2029-09
Study Type

Interventional

Study Phase

Phase3

No. of Participants

282

Intervention / Treatment

TCA108

Bramicar HCT

Sponsor

EMS

Source: clinicaltrials.gov

Share:
Add to list

Voice Quality Analysis of Patients With Laryngotracheal Stenosis

Study ID: NCT06161077
Start Date: 2026-07-01
End Date: 2028-12-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Voice Biomarker Screening Too

Sponsor

Johns Hopkins University

Source: clinicaltrials.gov

Share:
Add to list

Phase I Trial of BCMA-TGF-BETA CAR-T Cells in Relapsed, Refractory Myeloma

Study ID: NCT05976555
Start Date: 2026-03-01
End Date: 2029-05
Study Type

Interventional

Study Phase

Phase1

No. of Participants

30

Intervention / Treatment

BCMA-TGFβ CAR-T cells (0.50 x 10^6 cells/kg)

BCMA-TGFβ CAR-T cells (0.75 x10^6 cells/kg)

BCMA-TGFβ CAR-T cells (1 x 10^6 cells/kg)

BCMA-TGFβ CAR-T cells (2.5 x 10^6 cells/kg)

Maximum tolerated dose

Sponsor

Medical College of Wisconsin

Source: clinicaltrials.gov

Share:
Add to list

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

Study ID: NCT07061977
Start Date: 2026-06-26
End Date: 2030-12-31
Study Type

Interventional

Study Phase

Phase3

No. of Participants

336

Intervention / Treatment

Biospecimen Collection

Brachytherapy

Carboplatin

Chest Radiography

Cisplatin

Computed Tomography

External Beam Radiation Therapy

Intensity-Modulated Radiation Therapy

Magnetic Resonance Imaging

Paclitaxel

Pembrolizumab

Positron Emission Tomography

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Effect of an Exercise Program on Clinical Aspects of People With Diabetic Peripheral Neuropathy

Study ID: NCT07075367
Start Date: 2026-01-10
End Date: 2028-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

64

Intervention / Treatment

Proximal/distal protocol

Distal protocol

Sponsor

Federal University of Piauí

Source: clinicaltrials.gov

Share:
Add to list

Feasibility of Total Neoadjuvant Treatment With HYPErthermia in Patients With High-risk Extremity and Trunk Soft Tissue Sarcoma (TNT-HYPE)

Study ID: NCT06835049
Start Date: 2025-11-15
End Date: 2031-03-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

24

Intervention / Treatment

Doxorubicin

Ifosfamide

Dacarbazine

Hyperthermia

Radiotherapy

Surgery

Sponsor

Swiss Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list